职位

CRISPR Therapeutics

CRISPR Therapeutics

CRISPR Therapeutics

CRISPR Therapeutics AG is a Swiss–American biotechnology company headquartered in Zug, Switzerland. The company does business as CRISPR Therapeutics, Inc. in…

Gene Editing

Cell Therapy

Clinical Research

Bioinformatics

Molecular Biology

Zug, Canton of Zug

201-500

2013年成立(第13年)

混合办公

Public

估值

$2.9B

融资总额

$500M

CRSP

$59.5

CRISPR Therapeutics在招职位

9个在招职位

Senior Specialist, Site Supply Chain Planning

物流

Framingham, MA

现场办公

资深

全职

Senior Specialist, Drug Safety

South Boston, MA

现场办公

资深

全职

Executive Director, Clinical Development

医疗/健康科技

South Boston, MA

现场办公

总监级

全职

Executive Director, External Manufacturing & Supply Chain

物流

South Boston, MA

现场办公

总监级

全职

Research Associate II, CRISPR-X - LNP

机器学习

South Boston, MA

现场办公

应届/初级

全职

Director, LNP Discovery

医疗/健康科技

South Boston, MA

现场办公

总监级

全职

Associate Director, Clinical Scientist

医疗/健康科技

South Boston, MA

现场办公

总监级

全职

Senior Engineer II, mRNA Process Development

工程

South Boston, MA

现场办公

资深

全职

Senior Manager, Alliance Management

销售

South Boston, MA

现场办公

资深

全职

已关闭职位

41个职位

Senior Scientist, Oligonucleotide

South Boston, MA

资深

已关闭 3天前

Associate Director, Medical Safety

South Boston, MA

总监级

已关闭 3天前

Scientist II, LNP

South Boston, MA

中级

已关闭 1周前

Senior Manager, Drug Safety

South Boston, MA

资深

已关闭 3周前

Senior GXP Facilities Specialist

Framingham, MA

资深

已关闭 1个月前

产品与服务

Exagamglogene Autotemcel (exa-cel) for Sickle Cell Disease

Exagamglogene Autotemcel (exa-cel) for Sickle Cell Disease

Gene Therapy

CT

CTX001

Gene Therapy

CT

CTX110

Immuno-oncology

CR

CRISPR Platform Technology

Platform Technology

CT

CTX130

Immuno-oncology

Exagamglogene Autotemcel (exa-cel) for β-thalassemia

Exagamglogene Autotemcel (exa-cel) for β-thalassemia

Gene Therapy

TY

Type 1 Diabetes Program

Regenerative Medicine

CT

CTX131

Immuno-Oncology

CT

CTX120

Immuno-oncology

IN

In Vivo Gene Editing Platform

Gene Therapy

AU

Autoimmune Disease Programs

Autoimmune

HY

Hypoimmune Platform

Platform Technology

领导团队

DA

Daniel Anderson

Scientific Founders

SK

Stephen Kennedy

Head Of Technical Operations

RP

Raju Prasad

Chief Financial Officer

PKM

Phuong Khanh Morrow

Chief Medical Officer

浏览量

86

申请点击

0

模拟申请

0

收藏

0

评价

3.2

95条评价

工作生活平衡

2.8

薪酬

3.2

企业文化

3.0

职业发展

2.9

管理层

2.5

46%

推荐率

优点

Innovative projects

Good pay/compensation

Great team/colleagues

缺点

Work-life balance issues

Stressful/fast-paced environment

Management/leadership problems

薪资范围

70个数据点

Mid/L4

1份报告

-

年薪总额

基本工资

$110,000

股票

-

联系方式与地址